Willingness to switch to injectable cabotegravir among oral PrEP users in Durban, South Africa
Background: Adherence to daily oral pre-exposure prophylaxis (PrEP) is challenging. Long-acting injectable cabotegravir (CAB-LA), administered every two months, may improve adherence. Aim: To assess willingness to switch from oral PrEP to CAB-LA among adult PrEP users. Setting: PrEP users were recru...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Africânder |
| I whakaputaina: |
AOSIS
2025-10-01
|
| Rangatū: | Health SA Gesondheid: Journal of Interdisciplinary Health Sciences |
| Ngā marau: | |
| Urunga tuihono: | https://hsag.co.za/index.php/hsag/article/view/3120 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|